USPTO serial 79391728
GENOTHER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 16, 2025
- Examiner
- ANGOTTI, SALVATORE JOHN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GENOTHER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JANET G RICCIUTI
JANET G RICCIUTI JANET GILBERT RICCIUTI PC2003 Kalorama Road NW50 chemin de la BruyèreWASHINGTON, DC 20009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, veterinary products, namely gene and cell therapy products for the treatment of diseases in the nature of gene therapy preparations and genetically engineered pharmaceutical preparations for the treatment of diseases and disorders of genetic etiology; chemical preparations for medical and pharmaceutical use or for veterinary use, namely gene and cell therapy products for the treatment of diseases; biological preparations for medical and pharmaceutical use or for veterinary use, namely gene and cell therapy products for the treatment of diseases; enzyme preparations for medical and pharmaceutical use or for veterinary use, namely gene and cell therapy products for the treatment of diseases; microorganism cultures for medical and pharmaceutical use or for veterinary use; culture media for bacteriology; nutritional substances for microorganisms; preparations of micro-organisms, of genetically modified organisms and of cells for medical and pharmaceutical use or for veterinary use, particularly for gene therapy and cell therapy; compounds acting on genetic or other pathologies, in human beings and animals, particularly on muscle and neuromuscular diseases, diseases of the immune system, cardiovascular diseases, dermatological diseases, diseases of the central and peripheral nervous system, cancers, asthma, allergies, lipid disorders, obesity and diabetes and infectious diseases; kits for preparing cells or for selecting biologically active compounds comprised of gene therapies, namely biologically active cell preparations for the treatment of diseases and disorders of genetic etiology; diagnostic products for medical or veterinary use; diagnostic reagents for medical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology; diagnostic biomarkers for use in neuromuscular clinical research for medical use | ACTIVE | — |
| 009 | Electronic database in the field of medical patients; downloadable Software for artificial intelligence and machine learning software; downloadable mobile applications for artificial intelligence and machine learning software; downloadable Software as a Medical Device [SaMD]; downloadable computer programs for artificial intelligence and machine learning software; Computer platforms in the form of recorded or downloadable software for artificial intelligence and machine learning software | ACTIVE | — |
| 010 | Surgical, medical apparatus and instruments for medical use; testing apparatus for medical use for the diagnosis and/or follow-up the evolution of diseases namely genetic diseases; Diagnostic apparatus for medical use for the diagnosis and/or follow-up the evolution of diseases namely genetic diseases; cell culture instruments for medical use; surgical, medical apparatus and instruments intended for use in gene therapy and cell therapy; medical devices namely medical, biological and gene therapy testing kits to assist in collecting, assessing and determining optimal drugs and biological products comprising specimen transport tubes for use with blood, genetic materials, fluids, tissues, samples and other human components and related elements, frozen specimen bags, specimen collection and transport instructions, foam coolers for specimens, emergency medical service foam coolers for specimens, cardboard shipping containers for specimens, and shipping labels for specimens, all for medical use; medical devices, namely active implantable medical devices namely implantable drug delivery pumps and implantable drug delivery ports | ACTIVE | — |
| 035 | Business management assistance; commercial business appraisals; business management and organization consultancy; business management consultancy; Business expertise, in particular for start-up creation, mentoring programs; business information; business inquiries; commercial administration of the licensing of third-party goods and services; commercial or industrial company management assistance; advice on development strategy for scientific and technology projects (business management assistance); administrative management of contracts relating to research; price comparison services; establishing statistics; compilation of information into computer databases; systematization of data in a central file; computer file management; market research and studies; organization of fairs, exhibitions, trade fairs and job fairs for commercial or advertising purposes; searching for industrial or commercial partners; searching for financial partners; economic forecasting; sales promotion for others; advertising; commercial administration, commercial management advice, marketing advice, commercial strategy advice, business management advice, as well as office functions for the development and innovation of companies in the health sector; commercial feasibility studies, business appraisals, marketing studies, accounting, economic forecasting, and searching for sponsors to implement development plans for companies in the health sector; computerized file management for streamlining the business branches of companies in the health sector; administrative and commercial management and creation of services enabling the organization of networks and matching partners and/or service providers in areas of technological, innovation expertise, financing various projects; database management; compilation of information in computer databases; consultancy and advisory services with respect to company creation; advice and assistance to companies, particularly in the context of a program for the selection, coaching and acceleration of projects; sponsorship search; company audits (commercial analyses) | ACTIVE | — |
| 036 | Providing financing for inventions through, in particular, public financing ; financing services in the field of health; financial analysis; Financing appraisal through monitoring of use of public financing; providing financial information; administration and management of grants for medical research; providing financial subsidies; providing project grants for health awareness projects; financial investments; Investment research through, in particular, public financing; advice with respect to financing and investment; fundraising services; raising or investing capital; fund investment | ACTIVE | — |
| 041 | Education in the nature of digital training platforms, development of training digital content, photography and video for education purposes; training in the nature of organization of exhibitions for educational purposes, arranging and conducting of conferences, congresses and symposiums, publication of content; information relating to entertainment or education; publication of books; organization of competitions (education or entertainment); organization of exhibitions for cultural or educational purposes; electronic publication of books and journals online; electronic desktop publishing; organizing and conducting training workshops, colloquiums, conferences, congresses, seminars, symposiums for cultural or educational purposes; planning of receptions (entertainment); drafting and publication of texts other than advertising texts; publishing the results of clinical trials conducted on patients and scientific articles in relation to clinical and genetic diseases; providing non-downloadable electronic publications from a global computer network or the Internet; publishing services for magazines in paper and in electronic form | ACTIVE | — |
| 042 | Evaluations, assessments and research in the fields of science and technology provided by engineers; appraisals and assessments in the field of medical research; research in the medical field; industrial analysis and research services in the health sector; research and development of new products (for others); technical project studies; scientific research for medical purposes; clinical trials; medical research laboratory services; biological, bacteriological, gene and cell therapy, chemical and genetic research; programming of software for Internet platforms; hosting of platforms on the Internet; development of databases; providing imaging and physiology platforms; research and development of pharmaceutical, veterinary and sanitary products for third parties; sorting and selection of molecules; developing and validating biological tests, cell tests, genetic tests and immunological tests; fundamental and applied research in the scientific, technological or industrial field; technical research; activities in functional genomics for identifying, characterizing, validating or developing biologically active molecules; technical project study; professional consultancy unrelated to business operations in the field of scientific research and therapies | ACTIVE | — |
| 044 | Medical and surgical services; medical and surgical diagnosis; medical testing; hygienic and beauty care for human beings; health service; advice with respect to health; medical assistance; hospital services; nursing homes; convalescence or rest homes; consultation with respect to pharmacy; provision of information in the pharmaceutical field; medical imaging services; human tissue bank services; behavioral analysis for medical purposes; providing medical information; conducting medical examinations; medical consultation services; medical testing for the diagnosis and treatment of persons; genetic testing services for medical purposes; telemedicine services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GENETHON
- Other trademarks owned by GENETHON
- Other trademarks owned by GENETHON
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GENOTHER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 28, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 27, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 16, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 2, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 16, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 16, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 5, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 20, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 20, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 29, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 29, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 23, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 20, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 22, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 17, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 26, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 26, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 22, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 21, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |